Marhold, Maximilian http://orcid.org/0000-0001-8439-3312
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 16 February 2023
Accepted: 5 April 2023
First Online: 20 April 2023
Conflict of interest
: M. Marhold has received honoraria for lectures, writing, advisory board participation and consultation from Roche, Gilead, Eli Lilly, Novartis, Astra Zeneca, Daiichi Sankyo, Pfizer, MSD and Medmedia and travel support from MSD, Amgen, Gilead, Roche, Novartis, Pierre Fabre, Daiichi Sankyo and Eisai.